Literature DB >> 4020827

Synthesis and antiinflammatory and analgesic activity of 5-aroyl-1,2-dihydro-3H-pyrrolo[1,2-a]pyrrole-1-carboxylic acids and related compounds.

J M Muchowski, S H Unger, J Ackrell, P Cheung, G F Cooper, J Cook, P Gallegra, O Halpern, R Koehler, A F Kluge.   

Abstract

5-Acyl-1,2-dihydro-3H-pyrrolo[1,2-a]pyrrole-1-carboxylic acids and the homologous pyridine and azepine derivatives were synthesized and assayed for antiinflammatory and analgesic activity. 5-Benzoyl-1,2-dihydro-3H-pyrrolo-[1,2-a]pyrrole-1-carboxylic acid and the corresponding p-methoxy compound 74 were selected for evaluation as analgesic agents in humans on the basis of their high potency in the mouse phenylquinone writhing assay as well as on their minimal liability to elicit gastrointestinal erosion in rats on chronic administration. Extensive quantitative structure-activity relationship (QSAR) studies of the benzoylpyrrolopyrrolecarboxylic acids have demonstrated that the analgesic (mouse writhing) and antiinflammatory (rat carrageenan paw) potencies of these compounds are satisfactorily correlated with the steric and hydrogen-bonding properties of the benzoyl substituent(s). The 4-vinylbenzoyl compound 95, which was correctly predicted to be highly active in both assays on this basis, is undergoing advanced pharmacological evaluation in animals as a potential antiinflammatory agent.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4020827     DOI: 10.1021/jm00146a011

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  7 in total

1.  Pharmacokinetics of ketorolac and p-hydroxyketorolac following oral and intramuscular administration of ketorolac tromethamine.

Authors:  D Jung; E J Mroszczak; A Wu; T L Ling; H Sevelius; L Bynum
Journal:  Pharm Res       Date:  1989-01       Impact factor: 4.200

2.  Pharmacokinetics of ketorolac tromethamine in humans after intravenous, intramuscular and oral administration.

Authors:  D Jung; E Mroszczak; L Bynum
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

3.  Predictability of the clinical potency of NSAIDs from the preclinical pharmacodynamics in rats.

Authors:  A Mukherjee; V G Hale; O Borga; R Stein
Journal:  Inflamm Res       Date:  1996-11       Impact factor: 4.575

4.  QSAR and conformational analysis of the antiinflammatory agent amfenac and analogues.

Authors:  J Ruiz; M López; J Milà; E Lozoya; J J Lozano; R Pouplana
Journal:  J Comput Aided Mol Des       Date:  1993-04       Impact factor: 3.686

5.  Novel benzothiophene 1,1-dioxide deoxygenation path for the microwave-assisted synthesis of substituted benzothiophene-fused pyrrole derivatives.

Authors:  Hamza Karakuş; Yaşar Dürüst
Journal:  Mol Divers       Date:  2016-09-27       Impact factor: 2.943

6.  Crystal structures of methyl 3-(4-iso-propyl-phen-yl)-1-methyl-1,2,3,3a,4,9b-hexa-hydro-thio-chromeno[4,3-b]pyrrole-3a-carboxyl-ate, methyl 1-methyl-3-(o-tol-yl)-1,2,3,3a,4,9b-hexa-hydro-thio-chromeno[4,3-b]pyrrole-3a-carboxyl-ate and methyl 1-methyl-3-(o-tol-yl)-3,3a,4,9b-tetra-hydro-1H-thio-chromeno[4,3-c]isoxazole-3a-carboxyl-ate.

Authors:  R Raja; M Suresh; R Raghunathan; A SubbiahPandi
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2015-05-07

7.  Methyl 4-(tri-fluoro-meth-yl)-1H-pyrrole-3-carboxyl-ate.

Authors:  P A Suchetan; S Sreenivasa; B S Palakshamurthy; K E Manojkumar; S Madan Kumar; N K Lokanath
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2013-09-18
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.